Rui Ping Xiao

Title: Innovations of Rui Ping Xiao in Cardiac and Pulmonary Treatments

Introduction

Rui Ping Xiao is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating cardiac and pulmonary disorders. His work focuses on the discovery of effective analogues that can bind to specific receptors in the body.

Latest Patents

Rui Ping Xiao holds 1 patent related to his research. This patent concerns the discovery of (R,R)- and (R,S)-fenoterol analogues, which are highly effective at binding to β2-adrenergic receptors. The patent provides exemplary chemical structures for these analogues and includes pharmaceutical compositions that utilize the disclosed (R,R)-fenoterol and fenoterol analogues. These compounds and compositions are intended for the treatment of cardiac disorders such as congestive heart failure, as well as pulmonary disorders like asthma and chronic obstructive pulmonary disease.

Career Highlights

Rui Ping Xiao is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to important advancements in medical science and patient care.

Collaborations

Rui Ping Xiao has collaborated with notable colleagues in his field, including Irving William Wainer and Weizhong Zhu. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Rui Ping Xiao's contributions to the development of fenoterol analogues represent a significant advancement in the treatment of serious health conditions. His work continues to influence the pharmaceutical landscape and improve patient outcomes.